IBDEI0EM ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6676,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,6677,0)
 ;;=380.10^^31^413^50
 ;;^UTILITY(U,$J,358.3,6677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6677,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,6677,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,6677,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,6678,0)
 ;;=382.9^^31^413^51
 ;;^UTILITY(U,$J,358.3,6678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6678,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,6678,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,6678,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,6679,0)
 ;;=614.9^^31^413^52
 ;;^UTILITY(U,$J,358.3,6679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6679,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,6679,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,6679,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,6680,0)
 ;;=486.^^31^413^54
 ;;^UTILITY(U,$J,358.3,6680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6680,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,6680,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,6680,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,6681,0)
 ;;=136.3^^31^413^53
 ;;^UTILITY(U,$J,358.3,6681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6681,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,6681,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,6681,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,6682,0)
 ;;=601.9^^31^413^56
 ;;^UTILITY(U,$J,358.3,6682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6682,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,6682,1,5,0)
 ;;=5^Prostatitis Nos
 ;;^UTILITY(U,$J,358.3,6682,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,6683,0)
 ;;=590.80^^31^413^57
 ;;^UTILITY(U,$J,358.3,6683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6683,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,6683,1,5,0)
 ;;=5^Pyelonephritis Nos
 ;;^UTILITY(U,$J,358.3,6683,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,6684,0)
 ;;=711.00^^31^413^58
 ;;^UTILITY(U,$J,358.3,6684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6684,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,6684,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,6684,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,6685,0)
 ;;=461.9^^31^413^60
 ;;^UTILITY(U,$J,358.3,6685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6685,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,6685,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,6685,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,6686,0)
 ;;=473.9^^31^413^59
 ;;^UTILITY(U,$J,358.3,6686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6686,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,6686,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,6686,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,6687,0)
 ;;=091.0^^31^413^65
 ;;^UTILITY(U,$J,358.3,6687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6687,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,6687,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,6687,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,6688,0)
 ;;=097.0^^31^413^63
 ;;^UTILITY(U,$J,358.3,6688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6688,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,6688,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,6688,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,6689,0)
 ;;=094.9^^31^413^64
 ;;^UTILITY(U,$J,358.3,6689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6689,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,6689,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,6689,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,6690,0)
 ;;=097.9^^31^413^62
 ;;^UTILITY(U,$J,358.3,6690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6690,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,6690,1,5,0)
 ;;=5^Syphilis Nos
 ;;^UTILITY(U,$J,358.3,6690,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,6691,0)
 ;;=463.^^31^413^66
 ;;
 ;;$END ROU IBDEI0EM
